Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (161-170 of 248) with videos related to

Pageof 25
Sort By:
Blood|July 23, 2013
Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosisWen-Ming Peng, Laura Maintz, Jean-Pierre Allam, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostatMichaela Angelika Ihle, Sabine Merkelbach-Bruse, Wolfgang Hartmann, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomasGeorgios Kantidakis, Saskia Litière, Anouk Neven, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
The American Journal of Surgical Pathology|December 29, 2022
Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal TractAbbas Agaimy, Martina Baněčková, John De Almeida, et al.
Cancers|May 13, 2026
Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated PatientsJulie Zangarini, Axel Künstner, Florian Lenz, et al.
Human Pathology|August 22, 2008
KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutantsJerzy Lasota, Wojciech Kuban, Eva Wardelmann, et al.
Cold Spring Harbor Molecular Case Studies|July 7, 2017
Metastatic triple-negative breast cancer patient with <i>TP53</i> tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse eventsTobias Meißner, Adam Mark, Casey Williams, et al.
Science Signaling|September 13, 2022
Intestinal brush border formation requires a TMIGD1-based intermicrovillar adhesion complexChristian Hartmann, Eva-Maria Thüring, Lilo Greune, et al.
Pageof 25

Showing results (161-170 of 248) with videos related to

Sort By:
Pageof 25
Blood|July 23, 2013
Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosisWen-Ming Peng, Laura Maintz, Jean-Pierre Allam, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostatMichaela Angelika Ihle, Sabine Merkelbach-Bruse, Wolfgang Hartmann, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomasGeorgios Kantidakis, Saskia Litière, Anouk Neven, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
The American Journal of Surgical Pathology|December 29, 2022
Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal TractAbbas Agaimy, Martina Baněčková, John De Almeida, et al.
Cancers|May 13, 2026
Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated PatientsJulie Zangarini, Axel Künstner, Florian Lenz, et al.
Human Pathology|August 22, 2008
KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutantsJerzy Lasota, Wojciech Kuban, Eva Wardelmann, et al.
Cold Spring Harbor Molecular Case Studies|July 7, 2017
Metastatic triple-negative breast cancer patient with <i>TP53</i> tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse eventsTobias Meißner, Adam Mark, Casey Williams, et al.
Science Signaling|September 13, 2022
Intestinal brush border formation requires a TMIGD1-based intermicrovillar adhesion complexChristian Hartmann, Eva-Maria Thüring, Lilo Greune, et al.
Pageof 25